Mymust 100 mg Injection
  1. Home
  2. Pharma Products
  3. Mylan Pharmaceuticals Pvt Ltd
  4. Mymust 100 mg Injection

Mymust 100 mg Injection

Mymust 100 mg Injection contains bendamustine hydrochloride 100 mg, an alkylating anticancer medicine used for certain blood cancers. It is mainly used for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin lymphoma. The injection is administered intravenously by a qualified healthcare professional under medical supervision.

BUY NOW

Category

Bendamustine works by damaging the DNA of cancer cells, which interferes with their growth and multiplication. It may be used alone or with other anticancer medicines according to the prescribed chemotherapy protocol. Blood counts and clinical condition require monitoring because treatment can cause anemia, neutropenia, thrombocytopenia, nausea, fatigue, and infections. The dosage and treatment schedule are determined by the treating oncologist according to the patient’s condition and response to therapy.

Technical Specification

Specification Details
Active Ingredient Bendamustine Hydrochloride
Strength 100 mg
Dosage Form Lyophilized Powder for Injection
Route of Administration Intravenous
Pack Size 1 Vial, 20 mL
Manufacturer / Marketer Mylan Pharmaceuticals Pvt Ltd

Product Also Known As

Mymust 100 mg Injection, Mymust 100mg Injection, Mymust 100 mg Vial, Mymust 100mg Vial, Bendamustine 100 mg Injection, Bendamustine Hydrochloride 100 mg Injection, Bendamustine 100 mg Vial